GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
K

KeyMed Biosciences 2162.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

72.85

+5.12%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

18 analysts, 1 Mar 2026. The analysts' own views, not ours.

  • 7Strong buy
  • 10Buy
  • 1Hold
  • 0Sell
  • 0Strong sell

Price targets

Brokers' own targets, 21 Feb 2026. Not our view.

Last close 72.85Average target 85.05

Low
71.46
Average
85.05
Median
84.96
High
98.25

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028FY2029FY2030
RevenueCN¥1.45bnCN¥2.28bnCN¥3.27bnCN¥4.15bnCN¥4.72bn
Revenue, highestCN¥2.39bnCN¥2.81bnCN¥4.14bnCN¥5.69bnCN¥6.46bn
Revenue, lowestCN¥934.0mCN¥1.82bnCN¥2.42bnCN¥3.05bnCN¥3.46bn
Earnings per share3.230.081.51——
Earnings per share, highest3.980.262.35——
Earnings per share, lowest2.33-0.160.16——
Analysts131413116

Earnings against forecasts

Earnings per share by fiscal quarter

Q2 2026Q1 2026
Forecast5.31-1.46
Reported4.95-1.79
Difference-6.8%-22.5%

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

3 / 10

Revenue growth 0.0% a year over 10 years. Return on equity -18.3%.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.